Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

684
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
684
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interpretable graph neural networks for predicting drug activity in triple-negative breast cancer using scaffold-based splits.

Scientific reports·2026
Same author

Hybrid Vi+ECNN framework for advanced ADHD diagnostic accuracy in medical imaging.

Scientific reports·2026
Same author

Applications of transfer learning in sunflower disease detection: advances, challenges, and future directions.

Turkish journal of biology = Turk biyoloji dergisi·2025
Same author

Deep neural architectures for Kashmiri-English machine translation.

Scientific reports·2025
Same author

Dynamic Random Walk and Dynamic Opposition Learning for Improving Aquila Optimizer: Solving Constrained Engineering Design Problems.

Biomimetics (Basel, Switzerland)·2024
Same author

A Review and Comparative Analysis of Relevant Approaches of Zero Trust Network Model.

Sensors (Basel, Switzerland)·2024

Related Experiment Video

Updated: Sep 18, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K

Hybrid Deep Learning Architecture with Adaptive Feature Fusion for Multi-Stage Alzheimer's Disease Classification.

Ahmad Muhammad1, Qi Jin1, Osman Elwasila2

  • 1School of Information and Communication Engineering, University of Electronic Science and Technology of China, Chengdu 611731, China.

Brain Sciences
|June 26, 2025
PubMed
Summary
This summary is machine-generated.

A novel deep learning framework accurately classifies Alzheimer's disease (AD) stages using adaptive feature fusion. This approach integrates localized and global brain patterns from MRI scans, improving early diagnosis and patient care.

Keywords:
Alzheimer’s diseaseMRI classificationadaptive feature fusionconvolutional neural networksdeep learningneuroimagingvision transformers

More Related Videos

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

368

Related Experiment Videos

Last Updated: Sep 18, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

368

Area of Science:

  • Neuroimaging and Artificial Intelligence
  • Medical Diagnostics
  • Neurodegenerative Disorders

Background:

  • Alzheimer's disease (AD) diagnosis requires integrating localized brain changes with global connectivity.
  • Traditional deep learning models struggle with effectively combining these distinct feature types for AD classification.

Purpose of the Study:

  • To develop a novel deep learning framework for accurate multi-stage Alzheimer's disease (AD) classification.
  • To enhance diagnostic precision by dynamically integrating localized structural and global connectivity features from MRI scans.

Main Methods:

  • A deep learning framework utilizing T1-weighted MRI scans for AD classification.
  • An adaptive feature fusion layer employing an attention mechanism to integrate ResNet50 (CNN) and Vision Transformer (ViT) features.
  • Dynamic fusion of localized structural features (ResNet50) and global connectivity patterns (ViT).

Main Results:

  • Achieved 99.42% accuracy on the Alzheimer's 5-Class (AD5C) dataset, exceeding the previous benchmark by 1.18%.
  • Demonstrated the critical role of adaptive feature fusion in reducing misclassifications through ablation studies.
  • Confirmed robust generalizability via external validation on a four-class dataset.

Conclusions:

  • The proposed framework enables precise early diagnosis of Alzheimer's disease (AD).
  • Integration of multi-scale neuroimaging features facilitates timely and targeted interventions for optimized patient care.